As of 2026-03-16, the Intrinsic Value of Replimune Group Inc (REPL) is -19.07 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.14 USD, the upside of Replimune Group Inc is -367.03%.
Based on its market price of 7.14 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 367.03%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.07 - -19.07 | -19.07 | -367.03% |
| P/E | (83.89) - (106.31) | (92.66) | -1397.8% |
| DDM - Stable | (33.43) - (106.11) | (69.77) | -1077.2% |
| DDM - Multi | (2.28) - (5.55) | (3.22) | -145.1% |
| Market Cap (mil) | 589.55 |
| Beta | 0.20 |
| Outstanding shares (mil) | 82.57 |
| Enterprise Value (mil) | 539.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.61% |
| Cost of Debt | 5.00% |
| WACC | 9.16% |